KIP Infrastructure
2.12.2 - ci-build

KIP Infrastructure, published by Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S. This guide is not an authorized publication; it is the continuous build for version 2.12.2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/KIP-infrastructure/implementation-guide/ and changes regularly. See the Directory of published versions

CodeSystem: Treatment regimen

Official URL: https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen Version: 2.12.2
Active as of 2022-07-12 Computable Name: TreatmentRegimen

Treatment regimen

This Code system is referenced in the content logical definition of the following value sets:

This case-insensitive code system https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen defines the following codes:

CodeDisplayDefinition
toplusfem 2+5 eller lign, eks. CT 2+5 eller lign, eks. CT
aida AIDA AIDA
all_ved ALL vedligehold ALL vedligehold
atoatra ATO+ATRA ATO+ATRA
azacitidinmono Azacitidin monoterapi Azacitidin monoterapi
azacitidinvene Azacitidin-venetoclax Azacitidin-venetoclax
hydrea Hydrea Hydrea
hdara_c Hd-Ara-c +- supplement Hd-Ara-c +- supplement
ade ADE +- supplement ADE +- supplement
da DA +- supplement DA +- supplement
da31087 DA inkl. 3+10, 3+8, 3+7 DA inkl. 3+10, 3+8, 3+7
da31087my DA inkl. 3+10, 3+8, 3+7 + mylotarg DA inkl. 3+10, 3+8, 3+7 + mylotarg
da31087mi DA inkl. 3+10, 3+8, 3+7 + midostaurin DA inkl. 3+10, 3+8, 3+7 + midostaurin
flag FLAG +- supplement FLAG +- supplement
flagmito FLAG-Ida eller lign inkl FLAG, Mito-FLAG FLAG-Ida eller lign inkl FLAG, Mito-FLAG
flagmitovene FLAG-Ida eller lign inkl FLAG, Mito-FLAG + venetoclax FLAG-Ida eller lign inkl FLAG, Mito-FLAG + venetoclax
gilteritinib Gilteritinib Gilteritinib
idarac IdAraC IdAraC
inotuzumab Inotuzumab ozogamicin Inotuzumab ozogamicin
mace MACE +- supplement MACE +- supplement
midac MidAC MidAC
midostaurin_ved Midostaurin vedligehold Midostaurin vedligehold
ldara LdARA-C +- supplement LdARA-C +- supplement
atra ATRA ATRA
apl_mt APL-vedligeholdsbehandling APL-vedligeholdsbehandling
azacytidin_supplement 5-Azacytidin +- supplement 5-Azacytidin +- supplement
blinatumomab Blinatumomab Blinatumomab
vyxeos Vyxeos +- supplement Vyxeos +- supplement
nopho_2008 NOPHO-2008 NOPHO-2008
all_mt ALL vedligeholdelsesbehandling ALL vedligeholdelsesbehandling
other_ikke Anden ikke-intensiv Anden ikke-intensiv
other_eks Anden eksperimentel Anden eksperimentel
other_semi Anden semiintensiv (f.eks. Plan B) Anden semiintensiv (f.eks. Plan B)
other_int Anden intensiv (f.eks. BISHOP, Plan A) Anden intensiv (f.eks. BISHOP, Plan A)
hyper_cvad Hyper-CVAD Hyper-CVAD
alltogether_mt ALLtogether ALLtogether
experimental anden behl incl anden experimentel anden behl incl anden experimentel